Compliance Rate

Compliance Rate 51.23%
Compliant submissions 187
Incompliant submissions 178
Total trials 365

My Organizations' Clinical Trials

Showing 925 of 2400 entries
View as:

Putative Investigational Therapeutics in the Treatment of Patients With Known Ebola Infection

Phase: N/A Priority: Normal
NCT ID: NCT02363322 Org: User:
Start: 03/13/15 End: 12/31/17 Due: 12/31/18

Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00013689 Org: User:
Start: 03/31/01 End: 03/31/03 Due: 03/31/04

Phase I Dose Escalation SARS-CoV Recombinant S Protein, With and Without Adjuvant, Vaccine Study

Phase: N/A Priority: Normal
NCT ID: NCT01376765 Org: User:
Start: - End: - Due: -

Evaluation of the Efficacy of the Live Attenuated Tetravalent Dengue Vaccine Against DENV-2 and DENV-3 Challenge

Phase: N/A Priority: Normal
NCT ID: NCT03416036 Org: User:
Start: 11/28/17 End: 06/04/19 Due: 06/04/20

A Phase I Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel® With or Without GLA-AF for Intestinal Schistosomiasis in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT02337855 Org: User:
Start: 02/04/15 End: 01/27/17 Due: 01/27/18

A Comparison of Zidovudine (AZT) Used Alone or in Combination With Didanosine (ddI) or Dideoxycytidine (ddC) in HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00001022 Org: User:
Start: - End: 12/31/95 Due: 12/31/96

Phase I Trial to Determine the Safety and Pharmacokinetics of CRS3123.

Phase: N/A Priority: Normal
NCT ID: NCT02106338 Org: User:
Start: 06/30/14 End: 12/31/14 Due: 12/31/15

Evaluating the Safety, Tolerability, and Immunogenicity of a Prime-Boost Regimen of HIV-1 Nef/Tat/Vif, Env pDNA Vaccine Delivered Intramuscularly With Electroporation and HIV-1 rVSV envC Vaccine in Healthy, HIV-Uninfected Adults

Phase: N/A Priority: Normal
NCT ID: NCT02654080 Org: User:
Start: 03/31/16 End: 07/01/19 Due: 07/01/20

A Phase III Study to Evaluate the Safety and Efficacy of Ganciclovir (Dihydroxypropoxymethyl Guanine [DHPG]) Treatment of Symptomatic Central Nervous System (CNS) Congenital Cytomegalovirus (CMV) Infections.

Phase: N/A Priority: Normal
NCT ID: NCT00001100 Org: User:
Start: - End: 11/30/05 Due: 11/30/06

Asthma Phenotypes in the Inner City

Phase: N/A Priority: Normal
NCT ID: NCT01383941 Org: User:
Start: 08/31/11 End: 09/30/14 Due: 09/30/15

Valaciclovir to Prevent Transmission of Herpes Simplex Virus

Phase: N/A Priority: Normal
NCT ID: NCT00001649 Org: User:
Start: 08/31/97 End: 08/31/03 Due: 08/31/04

Safety, Tolerance and Pharmacokinetics of Raltegravir-Containing Antiretroviral Therapy in Infants, Children Infected With HIV and TB

Phase: N/A Priority: Normal
NCT ID: NCT01751568 Org: User:
Start: 11/12/14 End: 11/27/19 Due: 11/27/20

Analysis of HIV Genetic Variation in Patients Before Beginning Highly Active Antiretroviral Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00009256 Org: User:
Start: 04/13/00 End: 03/03/09 Due: 03/03/10

Using the Drug Thalidomide to Stimulate T Cells in HIV-Infected People

Phase: N/A Priority: Normal
NCT ID: NCT00053430 Org: User:
Start: 04/30/01 End: 02/28/06 Due: 02/28/07

Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00129259 Org: User:
Start: 09/30/05 End: 03/31/11 Due: 03/31/12

An Observational Study of People Who Have Recently Been Infected With HIV

Phase: N/A Priority: Normal
NCT ID: NCT00103961 Org: User:
Start: 01/31/04 End: 12/31/14 Due: 12/31/15

A Phase I Safety and Immunogenicity Study of Mix and Match of Licensed Flu Vaccine and Flumist

Phase: N/A Priority: Normal
NCT ID: NCT00231907 Org: User:
Start: 09/30/05 End: 03/31/07 Due: 03/31/08

Community Dynamics of Malaria Transmission in Humans and Mosquitoes at Maferinyah Sub-Prefecture, Guinea

Phase: N/A Priority: Normal
NCT ID: NCT04969913 Org: User:
Start: 03/07/22 End: 10/23/24 Due: 10/23/25

Experimental Vaccine for Plasmodium Falciparum Malaria

Phase: N/A Priority: Normal
NCT ID: NCT00340431 Org: User:
Start: 06/09/04 End: 02/06/08 Due: 02/06/09

Fluconazole Prophylaxis of Thrush in AIDS

Phase: N/A Priority: Normal
NCT ID: NCT00001542 Org: User:
Start: 07/31/96 End: 11/30/01 Due: 11/30/02

Expanded Dryvax Dilution Study in Previously Vaccinated Adults

Phase: N/A Priority: Normal
NCT ID: NCT00050505 Org: User:
Start: 10/31/02 End: 12/31/03 Due: 12/31/04

Nevirapine (NVP) Use to Prevent Mother-to-Child Transmission of HIV

Phase: N/A Priority: Normal
NCT ID: NCT00074399 Org: User:
Start: 02/28/01 End: 04/30/07 Due: 04/30/08

Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)

Phase: N/A Priority: Normal
NCT ID: NCT02519777 Org: User:
Start: 04/21/16 End: 01/05/21 Due: 01/05/22

Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis

Phase: N/A Priority: Normal
NCT ID: NCT00104299 Org: User:
Start: 01/31/05 End: 01/31/10 Due: 01/31/11

CMV Infection in Adolescent Males

Phase: N/A Priority: Normal
NCT ID: NCT00302029 Org: User:
Start: 06/30/06 End: 12/31/08 Due: 12/31/09